Advertisement

Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Clinical News Update

  • 8 Accesses

This is a preview of subscription content, log in to check access.

References

  1. 1.

    Schiffman M, Herrero R, Hildesheim A, et al. HPV DNA testing in cervical cancer screening: Results from women in a high-risk province of Costa Rica. JAMA 2000;283:87–93

  2. 2.

    Kuhn L, Denny L, Pollack A, Lorincz A, Richart RM, Wright TC. Human papillomavirus DNA testing for cervical cancer screening in low-resource settings. J Natl Cancer Inst 2000;92:818–825

  3. 3.

    Wright TC Jr, Denny L, Kuhn L, Pollack A, Lorincz A. HPV DNA testing of self-collected vaginal samples compared with cytologic screening to detect cervical cancer. JAMA 2000;283:81–86

  4. 4.

    Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999;189: 12–19

  5. 5.

    ALTS Study Group. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. J Natl Cancer Inst 2000; 92:397–402

  6. 6.

    Testing for HPV cost-effective in women with borderline smears. Lancet 2000; 355: 1247

Download references

Author information

Correspondence to Richard D. Press MD.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Press, R.D. Clinical News Update. Molecular Diagnosis 5, 245–251 (2000). https://doi.org/10.1007/BF03262083

Download citation

Keywords

  • Cervical Cancer
  • Cervical Cancer Screening
  • ARUP Laboratory
  • Viral Detection Method
  • Clinical Practice Committee